Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Orphanet J Rare Dis ; 19(1): 89, 2024 Feb 26.
Article in English | MEDLINE | ID: mdl-38409029

ABSTRACT

BACKGROUND: Rett syndrome (RTT) and tuberous sclerosis complex (TSC) are two rare disorders presenting with a range of different epileptic seizures. Seizure management requires careful therapy selection, thereby necessitating development of high-quality treatment guidelines. This targeted literature review (TLR) aimed to characterise country-specific and international treatment guidelines available for pharmacological management of seizures in RTT and TSC. METHODS: A TLR was performed between 25-Jan and 11-Mar 2021. Manual searches of online rare disease and guideline databases, and websites of national heath technology assessment bodies were conducted for the following countries: Australia, Canada, France, Germany, Israel, Italy, Japan, Spain, Switzerland, UK, and US as defined by pre-specified eligibility criteria. Search terms were developed for each condition and translated into local languages where appropriate. Eligible publications were defined as guidelines/guidance reporting pharmacological management of seizures in patients with RTT and TSC. Guideline development methodology, geographical focus, author information and treatment recommendations were extracted from guidelines. An author map was generated using R version 3.5.1 to visualise extent of collaboration between authors. RESULTS: 24 total guidelines were included, of which three and six contained only recommendations for RTT and TSC, respectively (some provided recommendations for ≥ 1 condition). Guideline development processes were poorly described (50% [12 guidelines] had unclear/absent literature review methodologies); reported methodologies were variable, including systematic literature reviews (SLRs)/TLRs and varying levels of expert consultation. Most (83% [20/24]) were country-specific, with guideline authors predominantly publishing in contained national groups; four guidelines were classified as 'International,' linking author groups in the US, UK, Italy and France. High levels of heterogeneity were observed in the availability of treatment recommendations across indications, with 13 and 67 recommendations found for RTT and TSC, respectively. For RTT, all treatment recommendations were positive and sodium valproate had the highest number of positive recommendations (Khwaja, Sahin (2011) Curr Opin Pediatr 23(6):633-9). All TSC treatments (21 medications) received either exclusively negative (National Organization for Rare Disorders (2019)) or positive (Chu-Shore et al. (2010) Epilepsia 51(7):1236-41) recommendations; vigabatrin received the highest number of positive recommendations (Kaur, Christodoulou (2019)). CONCLUSIONS: This review highlights the need for the development of international high-quality and comprehensive consensus-based guidance for the management of seizures with pharmacological therapy in RTT and TSC. TRIAL REGISTRATION: Not applicable.


Subject(s)
Epilepsy , Rett Syndrome , Tuberous Sclerosis , Humans , Rett Syndrome/drug therapy , Tuberous Sclerosis/complications , Tuberous Sclerosis/drug therapy , Epilepsy/drug therapy , Seizures/drug therapy , Valproic Acid/therapeutic use
2.
Sci Rep ; 9(1): 17057, 2019 11 19.
Article in English | MEDLINE | ID: mdl-31745223

ABSTRACT

Transcranial magnetic stimulation combined with electroencephalography is a powerful tool to probe human cortical excitability. The EEG response to TMS stimulation is altered by drugs active in the brain, with characteristic "fingerprints" obtained for drugs of known mechanisms of action. However, the extraction of specific features related to drug effects is not always straightforward as the complex TMS-EEG induced response profile is multi-dimensional. Analytical approaches can rely on a-priori assumptions within each dimension or on the implementation of cluster-based permutations which do not require preselection of specific limits but may be problematic when several experimental conditions are tested. We here propose an alternative data-driven approach based on PARAFAC tensor decomposition, which provides a parsimonious description of the main profiles underlying the multidimensional data. We validated reliability of PARAFAC on TMS-induced oscillations before extracting the features of two common anti-epileptic drugs (levetiracetam and lamotrigine) in an integrated manner. PARAFAC revealed an effect of both drugs, significantly suppressing oscillations in the alpha range in the occipital region. Further, this effect was stronger under the intake of levetiracetam. This study demonstrates, for the first time, that PARAFAC can easily disentangle the effects of subject, drug condition, frequency, time and space in TMS-induced oscillations.


Subject(s)
Anticonvulsants/standards , Electroencephalography/methods , Lamotrigine/pharmacology , Levetiracetam/pharmacology , Occipital Lobe/physiology , Transcranial Magnetic Stimulation/methods , Adult , Algorithms , Anticonvulsants/pharmacology , Brain Waves/physiology , Cross-Over Studies , Evoked Potentials, Motor/physiology , Female , Humans , Male , Young Adult
3.
J Neural Eng ; 15(4): 046024, 2018 08.
Article in English | MEDLINE | ID: mdl-29781808

ABSTRACT

OBJECTIVE: Constant changes in developing children's brains can pose a challenge in EEG dependant technologies. Advancing signal processing methods to identify developmental differences in paediatric populations could help improve function and usability of such technologies. Taking advantage of the multi-dimensional structure of EEG data through tensor analysis may offer a framework for extracting relevant developmental features of paediatric datasets. A proof of concept is demonstrated through identifying latent developmental features in resting-state EEG. APPROACH: Three paediatric datasets ([Formula: see text]) were analyzed using a two-step constrained parallel factor (PARAFAC) tensor decomposition. Subject age was used as a proxy measure of development. Classification used support vector machines (SVM) to test if PARAFAC identified features could predict subject age. The results were cross-validated within each dataset. Classification analysis was complemented by visualization of the high-dimensional feature structures using t-distributed stochastic neighbour embedding (t-SNE) maps. MAIN RESULTS: Development-related features were successfully identified for the developmental conditions of each dataset. SVM classification showed the identified features could accurately predict subject at a significant level above chance for both healthy and impaired populations. t-SNE maps revealed suitable tensor factorization was key in extracting the developmental features. SIGNIFICANCE: The described methods are a promising tool for identifying latent developmental features occurring throughout childhood EEG.


Subject(s)
Databases, Factual , Electroencephalography/methods , Epilepsy/physiopathology , Machine Learning , Signal Processing, Computer-Assisted , Adolescent , Child , Child, Preschool , Cohort Studies , Epilepsy/diagnosis , Female , Humans , Male , Retrospective Studies , Young Adult
4.
Epilepsy Behav ; 42: 98-106, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25506792

ABSTRACT

OBJECTIVE: We examined young adults' responses to information about sudden unexpected death in epilepsy (SUDEP). METHOD: Consecutive patients attending a specialist epilepsy clinic, aged 16-30years, with a Hospital Anxiety and Depression Scale (HADS) score of <11, and who had been told about SUDEP at least 2weeks previously, were invited to the study. Semistructured in-depth interviews were conducted by an experienced qualitative interviewer until data saturation was achieved. An inductive thematic analysis of the data was conducted, facilitated by the use of the qualitative data analysis software (NVivo). The study was approved by the South East Scotland Research Ethics Committee. RESULTS: Twenty-seven patients (15 females) aged 18-29years were interviewed. All said that they were satisfied with the information that they had received about SUDEP. However, at the interview, their understanding of SUDEP was often limited and incorrect. Many were not aware of their own SUDEP risk status. Twenty-two (81%) said that everyone should be told about SUDEP. Most thought that disclosure should happen at the time of the diagnosis or soon after, preferably in a face-to-face consultation; clinician judgment on timing was highlighted. Few reported seeking further information on SUDEP for themselves beyond the initial consultation. Most were either untroubled by the initial disclosure of SUDEP or reported initial anxiety that was not long-lasting. A minority reported changing their behavior, for example, improving medication adherence, but most reported no change. The majority expressed a fatalistic view of SUDEP as something outside of their control. SIGNIFICANCE: Our results suggest that clinicians can be more confident that most of their young adult patients want to know about SUDEP, want to be told early, and do not have long-lasting anxiety due to its disclosure. Getting information on SUDEP will not, on its own, increase medication adherence in most patients. Methods to increase patient understanding of SUDEP are needed.


Subject(s)
Death, Sudden , Epilepsy/psychology , Health Knowledge, Attitudes, Practice , Truth Disclosure , Adolescent , Adult , Anxiety/psychology , Female , Humans , Male , Qualitative Research , Risk , Young Adult
5.
Neuroimage Clin ; 3: 515-21, 2013.
Article in English | MEDLINE | ID: mdl-24273734

ABSTRACT

Prolonged febrile seizures (PFS) are the commonest cause of childhood status epilepticus and are believed to carry a risk of neuronal damage, in particular to the mesial temporal lobe. This study was designed to determine: i) the effect of prolonged febrile seizures on white matter and ii) the temporal evolution of any changes seen. 33 children were recruited 1 month following PFS and underwent diffusion tensor imaging (DTI) with repeat imaging at 6 and 12 months after the original episode of PFS. 18 age-matched healthy control subjects underwent similar investigations at a single time point. Tract-based spatial statistics (TBSS) was used to compare fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD) between patients and controls on a voxel-wise basis within the white matter skeleton. Widespread reductions in FA along multiple white matter tracts were found at 1 and 6 months post-PFS, but these had resolved at 12 months. At one month post-PFS the main changes seen were reductions in AD but at 6 months these had predominantly changed to increases in RD. These widespread white matter changes have not previously been noted following PFS. There are many possible explanations, but one plausible hypothesis is that this represents a temporary halting of normal white matter development caused by the seizure, that then resumes and normalises in the majority of children.

7.
Acta Neurol Scand Suppl ; 186: 21-4, 2007.
Article in English | MEDLINE | ID: mdl-17784533

ABSTRACT

Convulsive status epilepticus (CSE) in childhood is a medical emergency and its aetiology and outcome mean that it should be studied separately from adult CSE. The incidence in developed countries is between 17 and 23/100,000 with a higher incidence in younger children. Febrile CSE is the commonest single group with a good prognosis in sharp distinction to CSE related to central nervous system infections which have a high mortality. The aim of treatment is to intervene at 5 min and studies indicate that intravenous (i.v.) lorazepam may be a better first-line treatment than rectal diazepam and i.v. phenytoin a better second-line treatment than rectal paraldehyde. An epidemiological study strongly supports the development of prehospital treatment with buccal midazolam becoming a widely used but unlicensed option in the community. More than two doses of benzodiazepines increase the rate of respiratory depression without obvious benefit. The 1 year recurrence rate is 17% and the hospital mortality is about 3%.


Subject(s)
Benzodiazepines/administration & dosage , Seizures, Febrile/drug therapy , Seizures, Febrile/epidemiology , Status Epilepticus/drug therapy , Status Epilepticus/epidemiology , Age of Onset , Child , Child, Preschool , Emergency Medical Services/standards , Emergency Medical Services/trends , Encephalitis/complications , Encephalitis/physiopathology , Humans , Incidence , Infant , Infant, Newborn , Prognosis , Recurrence , Seizures, Febrile/physiopathology , Status Epilepticus/physiopathology , Time Factors
8.
Acta Neurol Scand ; 115(4 Suppl): 21-4, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17362272

ABSTRACT

Convulsive status epilepticus (CSE) in childhood is a medical emergency and its aetiology and outcome mean that it should be studied separately from adult CSE. The incidence in developed countries is between 17 and 23/100,000 with a higher incidence in younger children. Febrile CSE is the commonest single group with a good prognosis in sharp distinction to CSE related to central nervous system infections which have a high mortality. The aim of treatment is to intervene at 5 min and studies indicate that intravenous (i.v.) lorazepam may be a better first-line treatment than rectal diazepam and i.v. phenytoin a better second-line treatment than rectal paraldehyde. An epidemiological study strongly supports the development of prehospital treatment with buccal midazolam becoming a widely used but unlicensed option in the community. More than two doses of benzodiazepines increase the rate of respiratory depression without obvious benefit. The 1 year recurrence rate is 17% and the hospital mortality is about 3%.


Subject(s)
Pediatrics , Status Epilepticus/epidemiology , Status Epilepticus/therapy , Treatment Outcome , Adolescent , Female , Follow-Up Studies , Humans , Male , Retrospective Studies
9.
Arch Dis Child ; 90(1): 66-9, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15613516

ABSTRACT

AIMS: In children with convulsive status epilepticus (CSE) with fever, to determine the likelihood of acute bacterial meningitis (ABM), the proportion that are treated with antibiotics, and the proportion that have diagnostic CSF sampling. METHODS: Patients with an incident episode of CSE with fever were identified as part of an ongoing prospective population based study of CSE in childhood. RESULTS: There were 49 incident cases of CSE in the first six months. Ascertainment was 96%. Twenty four had CSE with fever, 16 had early parenteral antibiotics, nine had diagnostic CSF sampling, and four had ABM. The population risk of ABM in CSE with fever was significantly higher than that of short seizures with fever (17% v 1.2%). CONCLUSIONS: The classical symptoms and signs of ABM may be absent in CSE with fever. A high index of suspicion for ABM in the child with CSE with fever is paramount. The most appropriate management is suggested to be early parenteral antibiotics and a lumbar puncture when there are no contraindications.


Subject(s)
Fever/microbiology , Meningitis, Meningococcal/complications , Meningitis, Pneumococcal/complications , Status Epilepticus/microbiology , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Female , Humans , Infant , Male , Meningitis, Meningococcal/diagnosis , Meningitis, Meningococcal/drug therapy , Meningitis, Pneumococcal/diagnosis , Meningitis, Pneumococcal/drug therapy , Neisseria meningitidis , Prospective Studies , Streptococcus pneumoniae
10.
J Neurol Neurosurg Psychiatry ; 75(11): 1584-8, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15489391

ABSTRACT

OBJECTIVES: To characterise the clinical features, emergency pre-paediatric intensive care (PIC) treatment, and course of status epilepticus (SE) in children admitted to PIC. This may provide insight into reasons for admission to PIC and provide a framework for the development of strategies that decrease the requirement for intensive care. DESIGN: Cross sectional, retrospective study. SETTING: A tertiary paediatric institution's intensive care unit. PARTICIPANTS: The admission database and all discharge summaries of each admission to a tertiary paediatric institution's PIC over a three year period were searched for children aged between 29 days and 15 years with a diagnosis of SE or related diagnoses. The case notes of potential cases of SE were systematically reviewed, and clinical and demographic data extracted using a standard data collection form. RESULTS: Most children with SE admitted to PIC are aged less than 5 years, male to female ratio 1:1, and most (77%) will have had no previous episodes of SE. Prolonged febrile convulsions, SE related to central nervous system infection, and SE associated with epilepsy occur in similar proportions. Contrary to the Advanced Paediatric Life Support guidelines many children admitted to PIC for SE receive over two doses, or inadequate doses, of benzodiazepine. There is a risk of respiratory depression following administration of over two doses of benzodiazepine (chi2 = 3.4, p = 0.066). Children with SE admitted to PIC who had prehospital emergency treatment are more likely to receive over two doses of benzodiazepines (chi2 = 11.5, p = 0.001), and to subsequently develop respiratory insufficiency (chi2 = 6.2, p = 0.01). Mortality is low. Further study is required to determine the morbidity associated with SE in childhood requiring intensive care. CONCLUSIONS: As the risk of respiratory depression is greater with more than two doses of benzodiazepines, clinicians should not disregard prehospital treatment of SE. As pre-PIC treatment of SE is inadequate in many cases, appropriate audit and modifications of standard guidelines are required.


Subject(s)
Intensive Care Units, Pediatric/statistics & numerical data , Status Epilepticus/epidemiology , Unnecessary Procedures/statistics & numerical data , Adolescent , Algorithms , Anticonvulsants/administration & dosage , Anticonvulsants/adverse effects , Benzodiazepines/administration & dosage , Benzodiazepines/adverse effects , Child , Child, Preschool , Dose-Response Relationship, Drug , Emergency Medical Services/standards , Emergency Medical Services/statistics & numerical data , England , Female , Hospitals, Pediatric/statistics & numerical data , Humans , Infant , Infant, Newborn , Male , Patient Admission/statistics & numerical data , Practice Guidelines as Topic , Respiratory Insufficiency/chemically induced , Respiratory Insufficiency/epidemiology , Status Epilepticus/drug therapy , Utilization Review/statistics & numerical data
11.
Eur J Neurol ; 11(12): 800-10, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15667410

ABSTRACT

Population-based data on the incidence, aetiology, and mortality associated with status epilepticus (SE) are required to develop preventative strategies for SE. Through a systematic review, we aimed to assess the methodological quality as well as similarities, and differences between available population based studies in order to arrive at conclusions on the epidemiology of SE. All population-based studies where primary outcome was incidence, aetiology or mortality of SE were identified through a systematic search and synthesized. Methodological quality of studies were independently rated by two examiners using a unique scoring system. Seven population-based projects on SE yielding nine published reports and five abstracts were reviewed. Quality scores were in the range of 19-34 with a possible maximum of 40 (kappa scores 0.67-1.0). The incidence of SE has a bimodal distribution with peaks in children aged less than a year and the elderly. Most SE were acute symptomatic. Short-term mortality was 7.6-22% and long-term mortality was 43%. Age and aetiology were the major determinants of mortality. There are few population-based studies on SE but most are of good quality. Most studies are primarily or exclusively based on adult populations. There is limited information on the association of ethnicity and socio-economic status and SE.


Subject(s)
Outcome Assessment, Health Care , Population , Status Epilepticus/epidemiology , Age Distribution , Age Factors , Humans , Incidence , Prospective Studies , Review Literature as Topic , Risk Factors , Sex Distribution , Status Epilepticus/etiology , Status Epilepticus/mortality , Status Epilepticus/prevention & control , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...